Genitourinary complications of sickle cell disease

Journal of Urology

Volumn 166, Issue 3, 2001, Pages 803-811

  Bruno, Dieter ^b   Wigfall, Delbert R ^b   Zimmerman, Sherri A ^b   Rosoff, Philip M ^b   Wiener, John S ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Anemia, sickle cell; Kidney; Kidney neoplasms; Priapism; Urogenital system

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; HYDRALAZINE; INFUSION FLUID; MIDAZOLAM; MORPHINE SULFATE; PENTOXIFYLLINE;

HEMATURIA; HUMAN; IMPOTENCE; INFARCTION; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY MEDULLA; LIFE EXPECTANCY; PRIAPISM; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; URINARY TRACT INFECTION; UROGENITAL TRACT DISEASE;

EID: 0034879671     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65841-7     Document Type: Review

References (137)

1. Newborn screening for sickle cell disease and other hemoglobinopathies
2. Sickle cell syndromes and other hemoglobinopathies
3. Urological complications of sickle cell disease in a pediatric population
4. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia
5. E. Sickle cell anemia, a molecular disease
6. A specific chemical difference between the globins of normal human and sickle-cell anemia hemoglobin
7. Clinical laboratory diagnosis
8. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: Possible mechanism for microvascular occlusion in sickle cell disease
9. Vascular occlusion in sickle cell disease: Current concepts and unanswered questions
10. Enhanced platelet reactivity and hypercoagulability in the steady state of sickle cell anaemia
11. Anatomic lesions in sickle cell disease
12. Mortality in sickle cell disease. Life expectancy and risk factors for early death
13. Mortality in children and adolescents with sickle cell disease
14. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial
15. Levels of fetal hemoglobin necessary for treatment of sickle cell disease
16. Pain in sickle cell disease. Rates and risk factors
17. Fetal hemoglobin, sickling, and sickle cell disease
18. Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?
19. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
20. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial
21. Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease
22. Sickle cell nephropathy
23. Sickle cell nephropathy
24. Cryoprecipitable immune complexes, nephropathy, and sickle-cell disease
25. Nephropathy associated with sickle cell anemia: An autologous immune complex nephritis. I. Studies on nature of glomerular-bound antibody and antigen identification in a patient with sickle cell disease and immune deposit glomerulonephritis
26. Sickle cell disease and acute glomerulonephritis
27. Sickle-cell disease and poststreptococcal acute glomerulonephritis
28. Nephropathy associated with sickle cell anemia: An autologous immune complex nephritis. II. Clinicopathologic study of seven patients
29. Proteinuria and the nephrotic syndrome in homozygous sickle cell anaemia
30. Pathology of the glomerulus in sickle cell anemia with and without nephrotic syndrome
31. A histological appraisal of the kidney in the sickle cell anemia
32. Renal lesions in sickle cell nephropathy in children
33. Autologous immune complex nephritis associated with sickle cell trait: Diagnosis of the haemoglobinopathy after renal structural and immunological studies
34. Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study
35. Membranoproliferative glomerulonephritis associated with sickle cell disease in two siblings
36. Sickle cell nephropathy
37. Enuresis in sickle cell disease
38. Enuresis in sickle cell disease. I. Prevalence studies
39. Nocturnal enuresis in sickle cell haemoglobinopathies
40. Determinants of nocturnal enuresis in homozygous sickle cell disease
41. Renal hemodynamic studies in adults with sickle cell anemia
42. Renal abnormalities in patients with sickle cell-beta thalassemia
43. Survival analysis by sex, age group and hemotype in sickle cell disease
44. Causes of death in sickle-cell disease in Jamaica
45. Renal involvement in sickle cell-beta thalassemia
46. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme
47. Sickle cell disease
48. Altered vascular reactivity in sickle hemoglobinopathy. A possible protective factor from hypertension
49. Natural history of blood pressure in sickle cell disease: Risks for stroke and death associated with relative hypertension in sickle cell anemia
50. Acute renal failure in sickle cell anemia
51. Recurrent sickle cell nephropathy in a transplanted kidney
52. Bacteremia in sickle hemoglobinopathies
53. Predictors of urinary tract infection at the first prenatal visit
54. Sickle cell trait in pregnancy
55. Sickle trait and its association with birthweight and urinary tract infections in pregnancy
56. Priapism in children with sickle cell disease
57. Priapism of psychogenic origin
58. Pathology of sickle cell anemia
59. Priapism associated with sickle cell disease
60. Sickle cell anemia-clinical manifestations in 100 patients and review of the literature
61. Priapism in association with sickle hemoglobinopathies in children
62. Hematuria in sickle cell trait: The effect of intravenous administration of distilled water, urinary alkalinization, and diuresis
63. Intensive transfusion therapy for priapism in boys with sickle cell anemia
64. Prevalence of priapism in children and adolescents with sickle cell anemia
65. Priapism associated with the sickle cell hemoglobinopathies: Prevalence, natural history and sequelae
66. Priapism and impotence in homozygous sickle cell disease
67. Priapism as a complication of sickle cell disease
68. Priapism: A review of 46 cases
69. 99mTc penile scan: An investigative modality in priapism
70. Multisystem damage associated with tricorporal priapism in sickle cell disease
71. Priapism
72. Successful treatment of stutter priapism with an antiandrogen
73. Megalophallus in sickle cell disease
74. The management of priapism in sickle cell anemia
75. Autoxidation, dehydration, and adhesivity may be related to abnormalities of sickle cell erythrocytes
76. Impotence following childhood priapism
77. Priapism: A three-phase concept of management according to aetiology and prognosis
78. The ultrastructure of the erectile tissue in priapism
79. Priapism in childhood
80. Priapism associated with sickle cell hemoglobinopathy in children: Long-term effects on potency
81. Delayed high flow priapism: Pathophysiology and management
82. Traumatic laceration of intracavernosal arteries: The pathophysiology of nonischemic, high flow, arterial priapism
83. High flow priapism associated with sickle cell disease
84. Use of methylene blue and selective embolization of the pudendal artery for high flow priapism refractory to medical and surgical treatments
85. Priapism: A refined approach to diagnosis and treatment
86. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis
87. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism
88. Priapism: Review of 34 cases
89. Priapism: Etiology, treatment, and results in series of 35 presentations
90. Priapism in children with sickle cell anemia
91. Sickle cell anemia. Pathophysiology and treatment
92. Automated erythrocytopheresis for relief of priapism in sickle cell hemoglobinopathies
93. Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome
94. Neurologic events after partial exchange transfusion for priapism in sickle cell disease
95. Relief of sickle cell priapism by hydralazine. Report of a case
96. Studies on the vasoocclusive crisis of sickle cell disease IV. Mechanism of action of pentoxifylline (Trental)
97. Nitrendipine, nifedipine and verapamil inhibit the in vitro formation of irreversibly sickled cells
98. Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism
99. Successful surgical outcome in children with sickle hemoglobinopathies: The Duke University experience
100. A new operation for priapism
101. Cure of idiopathic priapism: New procedure for creating fistula between glans penis and corpora cavernosa
102. Changing surgical concepts in the treatment of priapism
103. Surgical management of priapism in children with sickle cell anemia
104. Venous bypass to control priapism
105. A new approach to the treatment of priapism
106. Penile prostheses in the management of impotence in sickle cell disease
107. Priapism in sickle cell disease: The case for early implantation of the penile prosthesis
108. Penile implant for intractable priapism associated with sickle cell disease
109. Stilboestrol and stuttering priapism in homozygous sickle-cell disease
110. Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism
111. Hydroxyurea in the treatment of sickle cell associated priapism
112. Testicular infarction associated with sickle cell disease
113. Segmental testicular infarction due to sickle cell disease
114. Testicular infarction in a patient with sickle cell trait
115. Renal medullary carcinoma. The seventh sickle cell nephropathy
116. Cancer as a marker of genetic medical disease: An unusual case of medullary carcinoma of the kidney
117. Renal medullary carcinoma: Clinical and therapeutic aspects of a newly described tumor
118. Renal collecting duct carcinoma in an 8-year-old child
119. Renal medullary carcinoma in patients with sickle cell trait
120. Renal medullary carcinoma associated with sickle cell trait: Radiologic findings
121. Re: Renal medullary carcinoma
122. Renal medullary carcinoma
123. Renal medullary carcinoma and sickle cell trait
124. Renal medullary carcinoma: A recently described highly aggressive renal tumor in young black patients
125. Renal medulla carcinoma in a white adolescent
126. Renal medullary carcinoma: Report of a case with positive urinary cytology
127. Renal medullary carcinoma: An aggressive neoplasm in patients with sickle cell trait
128. Prolonged survival of a patient with sickle cell trait and metastatic renal medullary carcinoma
129. Renal medullary carcinoma in an adolescent with sickle cell trait
130. Renal medullary carcinoma: A potential sickle cell nephropathy of children and adolescents
131. Renal medullary carcinoma: Can early diagnosis lead to long-term survival?
132. Renal medullary carcinoma: Prolonged remission with chemotherapy, immunohistochemical characterisation and evidence of bcr/abl rearrangement
133. Renal medullary carcinoma, a new clinico-pathological entity. Immunohistochemical, ultrastructural, flow cytometric and cytogenetic study of a case
134. Desmoplastic small round-cell tumor: Prolonged progression-free survival with aggressive multimodality therapy
135. Cancer incidence rate and mortality rate in sickle cell disease patients at Howard University Hospital: 1986-1995
136. Trends and patterns of mortality associated with birth defects and genetic diseases in the United States, 1979-1992: An analysis of multiple-cause mortality data